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Abstract
Background: In the last few years, several outbreaks of nosocomial infections caused by
multidrug-resistant pathogenic agents have been observed, and various biocides products were
developed in order to control this phenomenon. We investigated the efficacy of two natural
biodetergents composed of plants and kelps extracts, BATT1 and BATT2, against multidrug-
resistant strains.
Methods: In-vitro antibacterial efficacy of BATT1 and BATT2 against nosocomial multidrug-
resistant isolates was assessed using a suspension-inhibition test, with and without bovine serum
albumin (BSA). The test was also carried out on glass surfaces with and without BSA.
Results: In vitro tests with both biocidal disinfectants at 25% concentration demonstrated an
overall drop in bacterial, mould and yeast counts after 10 min of contact with or without organic
substances. For Pseudomonas aeruginosa, it was necessary to use undiluted disinfectants with and
without an organic substance. The same results were obtained in tests carried out on glass surfaces
for all strains.
Conclusions: The natural products BATT1 and BATT2 behave like good biocides even in
presence of organic substances. The use of both disinfectants may be beneficial for reducing
hospital-acquired pathogens that are not susceptible to disinfectants.
However, it has to be stressed that all these experiments were carried out in vitro and they still 
require validation from use in clinical practice.
Introduction
At present, biocides are an integral component of clinical
medicine, and serve to prevent the dissemination of noso-
comial pathogens in the hospital environment [1]. In the
last few years, despite remarkable progress in our knowl-
edge of risk factors, prevention and control measures, the
incidence of nosocomial infections has not decreased,
and many outbreaks have been caused by new multidrug-
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and often irrational use of antibiotics [2,3]. These micro-
organisms are resistant to the majority of antibiotics and
to many disinfectants, which has resulted in an increase in
environmental contamination [4,5]. In many cases, it has
been demonstrated that the molecular mechanisms
responsible for antibiotic resistance are the same as those
implicated in lack of susceptibility to biocides; anyway,
some biocides have the ability to select for antibiotic
resistant strains and vice versa [6-10]. Also, organic con-
tamination reduces the effectiveness of disinfectants and
antiseptics that are used extensively in medical and
healthcare facilities for the disinfection of mucous mem-
branes and wounds, and for the sterilization of medical
instruments and equipment surfaces that are often con-
taminated with organic materials. The influence of such
materials on the practical use of disinfectants should not
be ignored [11].
In the last few years, following the increased circulation of
pathogens that are not susceptible to several disinfectants,
many biocides and numerous in vitro tests have been
developed to assess the effectiveness of these products in
specific clinical applications [12]. NTI 30 C4281 BATT1
and NTI 30 C4282 BATT2 (Natural Technologies Italia
srl), referred to here as BATT1 and BATT2, are two new
natural biocides/detergents formulated with seaweed and
plant extracts and synergistic blends of surfactants derived
from kelp and other plants of low biological toxicity.
Alkyl-amino carboxylate is the active principle in both
products.
The aim of the present study was to assess the efficacy of
these biocides/detergents against multidrug-resistant
nosocomial bacteria.
Materials and methods
Disinfectants
Solutions of BATT1 and BATT2 disinfectants were pre-
pared by dilution in sterile water at 10, 15, 20 and 25%.
The bactericidal effects of BATT1 and BATT2 on multid-
rug-resistant nosocomial pathogens were assessed using a
suspension-inhibition test as recommended by the Euro-
pean Committee for Standardization (CEN) with or with-
out bovine serum albumin (BSA) 0.3 g/100 ml [13]. The
bactericidal effects of disinfectants were assessed using a
slightly modified suspension-inhibition test as recom-
mended by the CEN. The bactericidal effects of BATT1 and
BATT2 on reference strains were tested from manufacturer
(data not showed).
Culture methods
Environmental strains (Acinetobacter baumannii, Pseu-
domonas aeruginosa, methicillin-resistant Staphylococcus
epidermidis, methicillin-resistant Staphylococcus aureus,
high-level aminoglycoside-resistant Enterococcus faecalis,
extended-spectrum beta-lactamase (ESβL)-producing
Klebsiella pneumoniae, Candida albicans, Aspergillus fumiga-
tus and Legionella pneumophila ser.1) were isolated from
2002 to 2005 in the intensive care units (ICUs) of the Uni-
versity Hospital "Federico II" in Naples, Italy, during san-
itation checks following nosocomial outbreaks. These
microorganisms are recognized as the major hospital-
acquired pathogens that cause severe infections such as
pneumonia, septicaemia, urinary tract infections and sur-
gical site infections. Throughout this study, the isolates
per species were of the same clonal type, showing identi-
cal macrorestriction PFGE pattern (data not showed).
Swabs moistened with Brain-Heart Infusion broth were
used to sample horizontal surfaces and points of frequent
hand contact, as well as monitoring equipment, drug trol-
leys, respirators and sinks. Contact plates (Rodac; Interna-
tional PBI) with selective agar were used to sample other
surfaces (floor, walls and beds), and air was sampled
through the Surface Air System (International PBI). Cul-
ture specimens were enriched overnight at 37°C in Brain-
Heart Infusion broth and then subcultivated on agar
plates.
Isolates were identified by a commercial microidentifica-
tion system (API 20E; bioMèrieux, Marcy-L'Etoile,
France).
Environmental Legionella isolates were obtained from
multiple sites in patients' rooms. For each outlet, 2 l of hot
water was collected in a sterile bottle that contained 1 ml
of a 10 mg/ml solution of sodium thiosulphate. The water
temperature and residual free chlorine were determined
immediately after collection. Samples were concentrated
by filtration through cellulose acetate membrane filters
(0.22 μm pore size) and resuspended into 10 ml of the fil-
trate. Aliquots of the suspension were plated on to Buff-
ered Charcoal Yeast Extract (BCYE) agar with Legionella
Glycine, Vancomycin, Polymyxin B, Cycloheximide, and
Wadowsky and Yee selective supplements (Oxoid, Basing-
stoke, UK). Plates were incubated in 2.5% CO2 for 5 days
at 37°C and examined daily for evidence of growth.
Gram-negative typical colonies that required L-cysteine
for growth were harvested, centrifuged at 3000 rpm for 20
min and resuspended in sterile distilled water prior to
serological identification.
Resistance patterns of these microorganisms have been
determined as following.
Susceptibility testing and screening
Susceptibility tests of K. pneumoniae, A. baumannii and P.
aeruginosa were performed using the BD Phoenix (Phoe-
nix Technologies Ltd, San Jose, CA, USA) system (MIC/Page 2 of 6
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ANTIBIOTIC K. pneumoniae A.baumannii P. aeruginosa E. faecalis C. albicans A. fumigatus L. pneumophila
Amikacin <4 >32 >32
Amoxicillin-clavulanate >16/8 >16 >32
Ampicillin >16 >32
Ampicillin-sulbactam >16/8
Aztreonam >16
Cefazolin >16 >64
Cefepime 2
Cefotaxime >16 >32 >64
Ceftazidime >32 >16 >16
Ceftriaxone >32
Chloramphenicol 16 >16
Ciprofloxacin >2 >2 >2
Doxycycline >8
Erythromycin 1
Gentamicin ≤ 2 >8 >8
Gentamicin high-level >2000
Imipenem ≤ 1 >8 >8
Levofloxacin ≤ 1 >2 >2 >2
Meropenem ≤ 1 >8 >8
Netilmicyn high-level >2000
Nitrofurantoine ≤ 16 >512
Norfloxacine ≤ 2
Piperacillin >64 >64 16
Piperacillin-tazobactam ≥ 64/4 ≥ 64/4 16
Streptomycin high-level >2000
Tetracycline >8 >8
Trimethoprim-sulfamethoxazole ≤ 0.5/9.5 >2/38Page 3 of 6
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instructions (E. coli 25922 ATCC QC, P. aeruginosa ATCC
QC 27853, E. coli ATCC QC 35218)
ESβL activity in K. pneumoniae was evaluated using the
double-disc synergy test between cephalosporins or
monobactam and clavulanate disks on Muller Hinton
agar plates. ESβL activity was confirmed by Etest cefotax-
ime/cefotaxime+clavulanic and ceftazidime/ceftazidime +
clavulanic acid strip as recommended by the manufac-
turer (K. pneumoniae ATCC QC 700603).
High-level aminoglycoside resistance in E. faecalis was
determined in 96-well microtitre plates using Gentamicin
and streptomycin. For QC of HLAR screen tests was used
E. faecalis ATCC 29212.
Methicillin and vancomycin were used to test for resist-
ance in Staphylococcus spp. by antibiotic disc diffusion
method (S. aureus MRSA ATCC QC 43300).
Susceptibility testing of yeast and mould was detected by
E-test using C. albicans ATCC QC 90028 and A. fumigatus
ATCC 204305.
Finally, MICs for L. pneumophila were determined using
broth microdilution in liquid BCYE medium with selec-
tive supplement (L. pneumophila ser.1 ATCC QC 33152).
Throughout this study, results were interpreted according
to the Clinical and Laboratory Standards Institute (CLSI)
criteria for broth microdilution and disk diffusion meth-
ods [14].
Antimicrobial susceptibility testing showed common
multidrug-resistant antibiotypes for all the isolated micro-
organisms (Table 1). In particular, the antimicrobial sus-
ceptibility patterns of the ESβL-producing K. pneumoniae
showed resistance to penicillins, monobactams and third-
generation cephalosporins. Also the K. pneumoniae strain
was identified as ESβL-producer by Etest analysis (Table
2). The antimicrobial susceptibility analysis showed high-
level aminoglycoside-resistance in E. faecalis and methicil-
lin-resistance in Staphylococcus spp. that were either coag-
ulase positive or negative (data not showed).
In vitro quantitative suspension tests
Microbial suspensions in Luria-Bertani broth were pre-
pared from fresh cultures of the above microorganisms,
and subcultivated in non-selective media (Brain-Heart
Infusion agar for Gram-negative bacteria, Enterococcus and
Candida spp., Tryptone Soy Agar for Staphylococcus spp.,
Columbia Blood Agar for Aspergillus fumigatus). L. pneu-
mophila was cultivated on a selective medium, BCYE Agar
with selective supplements.
Final concentrations of inocula of 108 CFU/ml bacteria
and 106CFU/mL yeasts and moulds were measured using
a spectrophotometer (UV/VIS Lambda 2, PerkinElmer,
Monza, Italy) (OD660 0.08). A 100-μl suspension for each
test was added to tubes that contained 900 μl of sterile
physiological solution (control) or 900 μl of each disin-
fectant solution at different concentrations (10, 15, 20
and 25%), and left for 5, 10 and 15 min at 20 ± 2°C in a
thermostatic bath. Each inoculum was prepared twice,
with and without BSA 0.3 g/100 ml.
After incubation, 100 μl were removed from each inocu-
lum and smeared on Bacto D/E Neutralizing agar (Becton
Dickinson) after serial dilution
(1:10,1:100,1:1000,1:10000) in phosphate buffered
saline (PBS ph 7.4), in order to count the number of col-
onies surviving on each plate at different dilution. Accord-
ing to the standards, an efficacious biocide must reduce
the initial count by 4 or 5 log units, and the efficacy is esti-
mated by the ratio between the number of microorgan-
isms in the starting solution (inocula of 108 CFU/ml
bacteria and 106 CFU/mL yeasts and moulds) and number
of colonies surviving on neutralization plates. Plates were
incubated at 37°C for 24 h for bacterial strains and at
32°C for 72 h for C. albicans and A. fumigatus strains. Only
the aliquots of the reaction mixture (100 μl) that con-
5-Fluorocytosine >32*
Fluconazole >64*
Itraconazole >1* >1*
Amphotericin B >1* >2*
Table 1: Antimicrobial susceptibility patterns of strains tested (*Etest analysis). (Continued)
Table 2: MIC values of K. pneumoniae strain identified as ESβL-
producer (Etest analysis).
MIC of drug (mg/L)
K. pneumoniae CTX CTX+CLA CAZ CAZ+CLA
MIC >16 0.023 >32 0.125
CAZ: ceftazidime; CLA: clavulanic acid; CTX: cefotaximePage 4 of 6
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tion were added to 900 μl of neutraliser solution and left
at 20 ± 2°C for 3 min. After serial dilution as above, the
aliquots were smeared on BCYE agar with supplements.
These plates were incubated at 37°C in 2.5% CO2 for 5
days. The test was also carried out on glass surfaces ini-
tially contaminated with the microbial inocula, prepared
as above, for which the same concentrations were used as
for the suspension test, with and without BSA. After 5, 10
and 15 min of sanitation with both disinfectant solutions
at different concentration (10, 15, 20 and 25%), the sur-
faces were rinsed with a sterile physiological solution, and
100 μl was removed from the rinsing solution and
smeared on D/E Neutralizing agar after serial dilution.
Plates were incubated under the same conditions as
above. For L. pneumophila, it was only necessary to use the
neutraliser solution and selective medium. The experi-
ments were repeated three times on different days.
Results
In vitro quantitative suspension tests
Bacterial, mould and yeast concentration was evaluated
by colony counts on agar plates (Bacto D/E Neutralizing
agar, BCYE agar with supplements) after incubation under
the described conditions.
The results of the in vitro tests were interpreted in accord-
ance with the CEN Standards [13]. According to the stand-
ards, an efficacious biocide must reduce the initial count
by 4 or 5 log units, and the efficacy is estimated by the
ratio between the number of microorganisms in the start-
ing solution (inocula of 108 CFU/ml bacteria and
106CFU/mL yeasts and moulds) and number of colonies
surviving on neutralization plates.
Bactericidal activity of BATT1 and BATT2 was observed at
a concentration of 25% after 10 min contact. In vitro tests
with BATT1 and BATT2 demonstrated an overall drop in
microbial counts, without BSA (Table 3). The same results
were obtained in presence of BSA. To reduce P. aeruginosa
count, it was necessary to use 50%, 75% concentrations
and finally both undiluted disinfectants, with and with-
out BSA (data not shown). The same results were obtained
in the tests carried out on glass surfaces for all nosocomial
strains. Also in this test the biocide effect on P. aeruginosa
was obtained by using undiluted disinfectants with and
without an organic substance.
Discussion
Biodetergents BATT1 and BATT2 are natural products that
act as disinfectants and cleaning agents. In our experience,
this formulation from seaweed and plant extracts had
beneficial and effective results. In vitro tests showed an
Table 3: Experimental conditions and microbicidal effect of BATT1 e BATT2 on examined microorganisms
Microorganism BATT1-BATT2 
concentration
Contact
time 
(min)
Temp
(C°)
Organic load
(BSA g/100 ml)
Test
methodology
Inoculum
(log10)
Biocidal
activity
(log10 reduction)
without BSA
Biocidal
activity
(log10 reduction) 
with BSA
Acinetobacter 
baumannii
25% 10 20 ± 2 0.3 Suspension
Carrier
108 CFU/ml 8 8
Pseudomonas 
aeruginosa
undiluted 
disinfectants
10 20 ± 2 0.3 Suspension
Carrier
108 CFU/ml 8 8
MR Staphylococcus 
epidermidis
25% 10 20 ± 2 0.3 Suspension
Carrier
108 CFU/ml 8 8
MR Staphylococcus 
aureus
25% 10 20 ± 2 0.3 Suspension
Carrier
108 CFU/ml 8 8
ESβL-producing 
Klebsiella pneumoniae
25% 10 20 ± 2 0.3 Suspension
Carrier
108 CFU/ml 8 8
Candida albicans 25% 10 20 ± 2 0.3 Suspension
Carrier
106 CFU/mL 6 6
Aspergillus fumigatus 25% 10 20 ± 2 0.3 Suspension
Carrier
106 CFU/mL 6 6
HLAR Enterococcus 
faecalis
25% 10 20 ± 2 0.3 Suspension
Carrier
108 CFU/ml 8 8
Legionella pneumophila 
ser.1
25% 10 20 ± 2 0.3 Suspension
Carrier
108 CFU/ml 8 8Page 5 of 6
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min contact, with or without BSA, when the disinfectants
were used at a 25% concentration. These products are not
consumed by organic residues, which normally reduce the
activity of oxidising disinfectants such as chlorine and
ozone. The disinfectant effect of chlorine derivatives and
ozone occurs when the oxidation of organic substances
has been achieved, which implies the need for higher-
than-standard concentrations. However, increasing the
oxidising disinfectant concentration is not entirely with-
out risk. Evidence for the development of reduced suscep-
tibility caused by excessive exposure to disinfectants,
including quaternary ammonium compounds and bis-
biguanides, has been reported [15,16]. The use of BATT1
and BATT2 disinfectants, especially if alternate, may be
beneficial for reducing disinfectant-non-susceptible
microbes.
In the last few years, we have observed outbreaks of noso-
comial infections caused by multidrug-resistant patho-
gens that have been selected by excessive and often
irrational use of antibiotics and large use of disinfectants
[2,5]. Following increased circulation of pathogens that
are non-susceptible to several disinfectants, numerous in
vitro tests have been developed to assess the effectiveness
of various biocides in specific clinical situations [12]. In
the present study, the efficacy of the two natural biocides/
detergents BATT1 and BATT2 was assessed againstmultid-
rug-resistant strains isolated in the ICUs of University
Hospital "Federico II" in Naples during nosocomial out-
breaks. BATT1 and BATT2 disinfectants seem to be effica-
cious and cost-effective and may be useful in the control
of microbial contamination in hospital settings.
It has to be stressed, however, that the reported experi-
ments were carried out in vitro and have only a predictive
significance. The efficacy demonstrated by these surrogate
testing methods still requires validation from clinical
practice.
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